PPT-Bivalirudin with Provisional GPIIb/IIIa Inhibition – the

Author : myesha-ticknor | Published Date : 2016-03-20

Gregg W Stone MD Columbia University Medical Center Cardiovascular Research Foundation Bivalirudin vs Heparin GPI n18819 30d TIMI major or minor bleeding by treatment

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Bivalirudin with Provisional GPIIb/IIIa ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Bivalirudin with Provisional GPIIb/IIIa Inhibition – the: Transcript


Gregg W Stone MD Columbia University Medical Center Cardiovascular Research Foundation Bivalirudin vs Heparin GPI n18819 30d TIMI major or minor bleeding by treatment and study p lt 00001. 1 Competitive Inhibition Fig 8- 2 Competitive InhibitionCTEuli S + S E P + E c = K . ( [ c / K c / Vx sl re S bu i n a S bd t fee E a a s wre S bd c w S f fee E S Inhibition is a term used to describe the inability of a product being formed due to the presence of another substance (the inhibitor). Enzyme inhibition . can be competitive or noncompetitive. Competitive inhibition is caused when an inhibitor “competes” with the substrate in binding with the enzyme. Pratt & . Cornely. . Ch. 7. Other Factors. Other factors affect enzyme activity. Temperature. pH . pH Optimum. Determined by structural stability. Compartmentalization. Determined by active site residues. WAR. Unsuccessful:. Differing political views –Liberals . vs. . Sociallists. Summer Offensive . 1917- was a disaster, as the soldiers who fought the Germans became increasingly unwilling to fight and turned on each other and their officers. They had little control over the soldiers & no respect. They survived this however in the long run moderate social leaders, lost their credibility with soldiers and workers. . The boys and girls of the class IIIA of the Primary school in . Passignano. are happy to introduce you a story:. The bridge of friendship. Two farmers lived on the banks of a river, one on the right bank and the other on the left one. They quarrelled every day.. By: . Jingtian. . Weng. , Cindy Nguyen, Cassandra Lee, Sarah Bento-De Sousa. Presentation Date: Sept. 13, 2016. PHM142 Fall . 2016. Instructor: Dr. Jeffrey Henderson. What is COX?. Two homodimer enzymes COX-1 and COX-2. WAR. Unsuccessful:. Differing political views –Liberals . vs. . Sociallists. Summer Offensive . 1917- was a disaster, as the soldiers who fought the Germans became increasingly unwilling to fight and turned on each other and their officers. They had little control over the soldiers & no respect. They survived this however in the long run moderate social leaders, lost their credibility with soldiers and workers. . Bernardo Cortese. Intv. ’ . Cardiology. , A.O. Fatebenefratelli. bcortese@gmail.com. b. ernardocortese.com. Stone GW . NEJM.. 2008;358:2218-30. . Mehran. R . Lancet. .. . 2009;374:1149-59. Stone . . suo. . annus. . horribilis. : un update . scientifico. Bernardo Cortese. Intv. ’ . Cardiology. , A.O. Fatebenefratelli. bcortese@gmail.com. HORIZONS AMI. 30 . Day and 1-Year All-Cause Mortality. Platelets play a critical role in thromboembolic disease like ischemic heart disease and stroke . Platelets adhere to the diseased or damaged areas and become activated , exposing phospholipids and. GPIIb/IIIa. Inhibition-. The decrease in enzyme activity/loss of activity. exert effect by decreasing . affinity of the enzyme for the substrate. decreasing the amount of active enzyme available for catalysis. by a combination of these effects. During cardiopulmonary bypass procedures, systemic anticoagulation to prevent thrombosis in the patient as well as the circuit is utilized. Heparin is the most common agent used, but in selective cir The BRIGHT-4 Trial. Gregg W. Stone MD. On behalf of . Yaling. Han . and the . BRIGHT-4. investigators. Disclosure Statement of Financial Interest. Dr. Gregg W. Stone. Specific . to this topic: None. AMVAC Chemical Corporation. FMC Corporation. Gowan. Company. September 15-18, 2020. Outline of Presentation. Introduction to Testing Program (Rick Reiss) – 15 minutes. Experimental Procedures and Results (Jan Chambers) – 20 minutes.

Download Document

Here is the link to download the presentation.
"Bivalirudin with Provisional GPIIb/IIIa Inhibition – the"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents